85 related articles for article (PubMed ID: 320260)
1. Inhibition of C1s-induced vascular leakage in guinea pigs by substituted benzamidine and pyridinium compounds.
Andrews JM; Rosen FS; Silverberg SJ; Cory M; Schneeberger EE; Bing DH
J Immunol; 1977 Feb; 118(2):466-71. PubMed ID: 320260
[TBL] [Abstract][Full Text] [Related]
2. The inactivation of human C1 by benzamidine and pyridinium sulfonylfluorides.
Bing DH; Cory M; Doll M
J Immunol; 1974 Aug; 113(2):584-90. PubMed ID: 4845666
[No Abstract] [Full Text] [Related]
3. C1s-induced vascular permeability in C2-deficient guinea pigs.
Strang CJ; Auerbach HS; Rosen FS
J Immunol; 1986 Jul; 137(2):631-5. PubMed ID: 3487577
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of four human serine proteases by substituted benzamidines.
Andrews JM; Roman DP; Bing DH
J Med Chem; 1978 Dec; 21(12):1202-7. PubMed ID: 152812
[TBL] [Abstract][Full Text] [Related]
5. Differences in activation of human and guinea pig complement by retroviruses.
Bartholomew RM; Esser AF
J Immunol; 1978 Nov; 121(5):1748-51. PubMed ID: 213489
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
Glovsky MM; Cory M; Alenty A
Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
Hauptmann J; Markwardt F
Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
[No Abstract] [Full Text] [Related]
8. [Mechanism of substance P-induced increase in vascular permeability in guinea pig skin].
Iwamoto I
Arerugi; 1989 Mar; 38(3):239-45. PubMed ID: 2473726
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies.
Gupta SP; Handa A; Shewade DG
Arzneimittelforschung; 1987 Jan; 37(1):47-50. PubMed ID: 2952126
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acrosin by benzamidines.
Stürzebecher J
Acta Biol Med Ger; 1981; 40(10-11):1519-22. PubMed ID: 7044006
[TBL] [Abstract][Full Text] [Related]
11. Effect of C1-inhibitor, benzamidine, and heat treatment on the hydrolytic activity of a subcomponent of the first component of human complement, C1s.
Takahashi K; Nagasawa S; Koyama J
Biochim Biophys Acta; 1980 Jan; 611(1):196-204. PubMed ID: 7350917
[No Abstract] [Full Text] [Related]
12. Aromatic tetra-amidines: antiproteolytic and antiesterolytic activities towards serine proteinases involved in blood coagulation and clot lysis.
Ferroni R; Menegatti E; Orlandini P; Guarneri M; Taddeo U; Bolognesi M; Ascenzi P; Bertollini A; Amiconi G
Farmaco Sci; 1986 Jun; 41(6):464-70. PubMed ID: 3527742
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of serine proteinases by benzamidine derivatives.
Walsmann P
Acta Biol Med Ger; 1977; 36(11-12):1931-7. PubMed ID: 616739
[TBL] [Abstract][Full Text] [Related]
14. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
Kaiser B; Hauptmann J; Markwardt F
Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of a synthetic amide substrate by human C1 esterase (C1s).
Morgan PH; Nair IG
J Immunol; 1977 Jul; 119(1):19-25. PubMed ID: 17638
[No Abstract] [Full Text] [Related]
16. Inhibition of bFGF activity by complement C1s: covalent binding of C1s with bFGF.
Sakiyama H; Kaji K; Nakagawa K; Nagino K
Cell Biochem Funct; 1998 Sep; 16(3):159-63. PubMed ID: 9747507
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological manipulation of complement system.
Asghar SS
Pharmacol Rev; 1984 Dec; 36(4):223-44. PubMed ID: 6395140
[No Abstract] [Full Text] [Related]
18. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
[No Abstract] [Full Text] [Related]
19. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
Betz SJ; Page N; Estrade C; Isliker H
J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of alpha-chyjotrypsin gy benzamidine derivatives].
Richter P; Klyosov A
Pharmazie; 1976; 31(3):192-3. PubMed ID: 959277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
